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BACKGROUND Although the prevalence of acute kidney injury (AKI) associated with
acute coronary syndrome management is well-described, similar knowledge
regarding AKI in patients being treated for critical limb ischemia (CLI) is poor. We
determined the prevalence of and clinical characteristics associated with AKI in pa-
tients admitted with CLI undergoing revascularization.
METHODS We prospectively studied 189 patients presenting to a single academic
medical center with CLI, deﬁned as Rutherford class IV-VI. Patients underwent either
lower extremity bypass surgery or endovascular intervention. Demographics, proce-
dural and clinical variables were collected. Patients were followed for the occurrence
of AKI as well as major adverse cardiac and limb events. AKI was diagnosed based on
changes in serum creatinine during the hospitalization in accordance with AKIN
criteria, deﬁned as either a 1.5 fold increase or 0.3 mg/dL absolute increase in serum
creatinine (Cr) from baseline. Comparisons between the two groups were performed
using Fischer exact and t-testing.
RESULTS Of the 115 patients included in the analysis, 31 patients (27%) developed
AKI. 74 patients were excluded because they did not undergo a bypass or endovas-
cular procedure or they were on dialysis. There was no difference in demographic or
clinical characteristics between patients who did and did not develop AKI. Compared
to those who did not develop AKI, patients who developed AKI had on average a
longer length of hospital stay (16d vs. 29d, p<0.01) and a longer length of ICU days
(2d vs. 7d, p¼0.04). In addition to signiﬁcantly higher peak Cr values (2.8 vs. 1.1,
p<0.01), patients who developed AKI also had signiﬁcantly higher discharge Cr values
compared to those who did not develop AKI. The development of AKI in the bypass
versus endovascular groups approached statistical signiﬁcance (36% vs. 21%,
p¼0.06). There was no signiﬁcant difference in adverse inpatient cardiac and limb
events between individuals who did and did not develop AKI.
CONCLUSION The development of AKI is common in individuals admitted for
CLI and is associated with a longer hospital stay and number of days spent in the
ICU. The difference between the development of AKI in the endovascular versus
the bypass group did not reach statistical signiﬁcance, however, it may have if our
study had more power. Studies trying to identify individuals who may be at increased
risk for AKI and to determine whether the development of AKI is associated with
increased adverse long-term cardiac and limb events will be important.NEUROVASCULAR INTERVENTION
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BACKGROUND Chronic cerebrospinal venous insufﬁciency is a syndrome character-
ized by stenoses or obstructions of the internal jugular and/or azygous veins. Venous
narrowings are related to intraluminal defects such as webs, ﬁxed valve leaﬂet,
membrane, inverted valve position or congenital segmental hypoplasia. The rela-
tionship between global hypoperfusion of the brain, deﬁcient blood drainage and
cerebrospinal ﬂuid ﬂow is discussed. The purpose of the study was to evaluate the
effect of angioplasty on the clinical disability and quality of life (QoL) in MS patients 2
years after the procedure.
MATERIALS AND METHODS In our study trial (64 patients) - relapsing-remitting and
patients with progressive course of disease were included. Fatigue was assessed by
the Fatigue Severity Scale (FSS) and modiﬁed Fatigue Impact Scale (MFIS). QoL was
evaluated by a simple Visual Analogue Scale (VAS) and Multiple Sclerosis Impact Scale
29 (MSIS-29). Gait speed was assessed by Timed 25-Foot Walk test (T25FW). The
bladder dysfunction was graded by Overactive Bladder Self-Administered
Questionnaire.
RESULTS In the study, an important improvement was achieved in the clinical
disability of relapsing-remitting patients after 2 years of angioplasty (mean EDSS 2.96 1.73 vs 1.92  1.82). Using T25FW gait speed signiﬁcantly (p < 0.001) increased in
70% of MS patients. An amelioration of gait speed in RR group was achieved in 20%
and 27% in patients with advanced course of disease, respectively. There is a sig-
niﬁcant decrease in FSS and MFIS score in both patient groups indicating the
improvement of fatigue (p < 0.001). Fatigue was more frequent in patients with
advanced course of disease (40%). An important amelioration of QoL using VAS and
MSIS-29 scale was observed in RR and progressive patients group (p < 0.001). In
addition, an improvement of bladder function in both groups of patients was ob-
tained (p < 0.001).
CONCLUSION The deﬁcient immunomodulatory treatment of MS is a challenging
factor to search for an additional way to prevent and slow the course and the
disability of this very debilitating disease. Improving the cerebral venous drainage is a
promising step in the amelioration of the central nervous system function.OTHER
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BACKGROUND Peripheral arterial disease (PAD) represents atherosclerotic disease in
the large-vessel arterial beds excluding the coronary and cerebral circulation. PAD is
asymptomatic in 50% of patients which often delays diagnosis. Early recognition can
minimize complications such as limb loss and prevent cardiovascular complications, a
major cause of morbidity and mortality in these patients. AHA/ACCF guidelines
released in 2005 and 2011 have focused on augmenting PAD surveillance. The goal of
this study is to evaluate the response to guidelines by measuring new diagnoses of
PAD from 2006-2013 at an urban, university medical center.
METHODS Medical records of patients newly diagnosed with peripheral arterial dis-
ease from 2006-2013 were evaluated under the premise of intuitional IRB. There were
no exclusion criteria. Patient age, gender, and ethnicity were obtained. An anony-
mous database which maintained patient conﬁdentiality was created with new di-
agnoses of PAD grouped by their respective months and years.
RESULTS Medical records of 758,927 patients were surveyed for the diagnosis of PAD.
The total patients seen increased annually, from 74,666 patients in 2006 to 126,683
patients in 2013. Average age of the patient population increased (47.234 years-49.374
years) over the eight year period. 5,242 patients (2628 males, 2614 females) were
diagnosed with PAD. The incidence of PAD increased from 2006-2009 (0.00715-
0.00860) and decreased from 2009-2013 (0.00860-0.00429). The average age at
diagnosis did not follow a linear trend but increased from 65.227 years to 69.864 years
from 2009-2013.
CONCLUSION Individuals with peripheral arterial disease (PAD) have higher
morbidity and mortality due to cardiovascular causes. This study is of interest
because despite a growing, aging patient population and a recommended earlier age
of surveillance, the ﬁndings show an overall decline in incidence of PAD and an
increasing age at diagnosis from 2006-2013. Suspected lack of guideline awareness,
dearth of primary care literature about PAD, and insufﬁcient diagnostic experience
among primary care physicians may explain these ﬁndings. Further research about
guideline efﬁcacy and physician awareness of PAD should be performed.PERIPHERAL VASCULAR INTERVENTION
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BACKGROUND Percutaneous transluminal angioplasty has historically been the
standard in minimally invasive treatment of peripheral artery disease (PAD). In iliac
arteries, self-expanding, nitinol stent technology has evolved as an effective treat-
ment of atherosclerotic lesions. BIOFLEX-I evaluates the safety and efﬁcacy of the
Astron stent in the iliac arteries.
METHODS The BIOFLEX-I study was a prospective, multicenter, non-randomized,
single arm, investigational device exemption (IDE) study performed in the United
States, Canada, and Europe. Thirty (30) study centers enrolled 161 evaluable study
subjects for treatment of de novo or restenotic lesions (140mm length) or occlusions
(100mm length) in common and/or external iliac arteries with reference vessel di-
ameters from 6 to 9mm. The primary endpoint was the composite rate of procedure or
stent related major adverse events (MAEs) at 12 months post index procedure. MAEs
were deﬁned as 30-day mortality, clinically-indicated target lesion revascularization
(TLR) and index limb amputation at 12 months. Results were compared to a pre-
speciﬁed performance goal based on prior prospective, multicenter studies utilizing
